BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

11471 related articles for article (PubMed ID: 1502357)

  • 1. [Role of MR in characterizing expansive lesions of the adrenal gland].
    Squillaci E; Vidiri A; Crecco M; Lo Presti G; Simonetti G
    Radiol Med; 1992 Jun; 83(6):770-6. PubMed ID: 1502357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
    Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
    Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenal myelolipomas: their magnetic resonance assessment].
    Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Di Vito A; Perri G
    Clin Ter; 1996 Nov; 147(11):549-57. PubMed ID: 9264908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of the adrenal gland.
    Boland GW; Lee MJ
    Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of spondylodiscitis with magnetic resonance. Use of gadolinium-DTPA].
    Duca S; Lo Bello G; Bianchi G; Di Paola A
    Radiol Med; 1993 Nov; 86(5):587-94. PubMed ID: 8272542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
    Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
    Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of the modified Dixon technique associated with gadolinium administration in the characterization of adrenal masses].
    Boraschi P; Braccini G; Gigoni R; Cartei F; Campatelli A; Vito AD; Perri G
    Radiol Med; 1997 Mar; 93(3):218-24. PubMed ID: 9221413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Errors of magnetic resonance in the diagnosis of small renal tumors].
    Del Viscovo L; Ginolfi F; Rotondo A; Smaltino F
    Radiol Med; 1993 Dec; 86(6):847-50. PubMed ID: 8296006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of magnetic resonance in characterizing focal liver lesions].
    Colagrande S; Bartolozzi A; Tonarelli A
    Radiol Med; 1994 Apr; 87(4):469-81. PubMed ID: 8190931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of magnetic resonance in the study of benign and malignant pheochromocytomas. Quantitative analysis of the intensity of the resonance signal].
    Maurea S; Cuocolo A; Reynolds JC; Choyke PL; Keiser HR; Neumann RD; Salvatore M
    Radiol Med; 1993 Jun; 85(6):803-8. PubMed ID: 8337438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
    Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging of thymic epithelial tumors.
    Kushihashi T; Fujisawa H; Munechika H
    Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The contribution of gadolinium to the magnetic resonance diagnosis of spondylodiscitis].
    Dalla Palma L; Pozzi-Mucelli R; Cova M; Iannis MR; Pagnan L
    Radiol Med; 1991 Oct; 82(4):393-400. PubMed ID: 1767043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 574.